SCHEDULE 13D/A: Major Investor Amends Stake in Alphatec Holdings, Disclosing 6.45% Beneficial Ownership
Beneficial Ownership Amendment Filing
L-5 Healthcare Partners, LLC and Paul Segal have filed an Amendment No. 8 to their Schedule 13D, revealing a 6.45% beneficial ownership stake in Alphatec Holdings, Inc.
Summary
- L-5 Healthcare Partners, LLC and Paul Segal collectively beneficially own 9,214,698 shares of Alphatec Holdings, Inc. Common Stock.
- This ownership represents 6.45% of the company's total outstanding Common Stock.
- The reported stake includes 8,081,538 shares of Common Stock directly held and an additional 1,133,160 shares of Common Stock issuable upon the exercise of a warrant.
- The percentage of ownership is calculated based on 141,815,115 shares of Common Stock outstanding as of November 13, 2024, as reported in the Issuer's Form S-3ASR filed on November 15, 2024, combined with the 1,133,160 warrant shares.
- This filing is an Amendment No. 8 to the previously filed Schedule 13D, indicating an update to their beneficial ownership position.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing (Schedule 13D Amendment) disclosing beneficial ownership. It is factual and does not contain explicit positive or negative sentiment regarding the company's performance or outlook. The continued significant stake by a major investor could be interpreted as a neutral to mildly positive signal.
Positives
- A significant institutional investor, L-5 Healthcare Partners, LLC, along with Paul Segal, maintains a substantial 6.45% beneficial ownership stake in Alphatec Holdings, Inc., which can be interpreted as a continued vote of confidence in the company.
Future Outlook
NA
Management Comments
- Paul Segal disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency regarding significant beneficial ownership, which can influence market perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| November 13, 2024 | Date as of which 141,815,115 shares of Common Stock were reported outstanding by the Issuer. |
| November 15, 2024 | Date Alphatec Holdings, Inc. filed its Form S-3ASR, reporting the number of outstanding shares. |
| February 4, 2025 | Date of the event which required the filing of this statement (triggering event for the amendment). |
| February 6, 2025 | Signature date of the Schedule 13D Amendment No. 8 filing. |
Keywords
Alphatec Holdings, ATEC, L-5 Healthcare Partners, Paul Segal, Schedule 13D, Beneficial Ownership, Common Stock, SEC Filing, Investment
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.